Integrated Clinicopathology and Biorespository Core

综合临床病理学和生物仓库核心

• 批准号: 8588551
• 负责人: Matthew D Ringel
• 金额: $ 27.9万
• 依托单位: OHIO STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-25 至 2018-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8588551
• 关键词: Back; Basic Science; Biological; Blood specimen; Cancer Center; Clinical; Clinical Data; DNA; Data; Ensure; Formalin; Freezing; Goals; Human; Institution; Instruction; Knowledge; Malignant - descriptor; Malignant neoplasm of thyroid; Ohio; Outcome; Paraffin Embedding; Process; Quality Control; Research; Research Activity; Resources; Sampling; Services; Specimen; TNFRSF5 gene; Techniques; Thyroid Gland; Tissue Sample; Tissues; Translating; Translational Research; Universities; Validation; bench to bedside; biobank; clinical care; novel; peripheral blood; prospective; sample collection; sound

The goal of this Core is to provide high quality clinical data and subject samples for use in the scientific projects of the SPORE. To provide these resources. Core A will utilize and expand upon clinical and biospecimen resources that already exist at each institution. For projects in which additional or different samples/data are required, prospective collection of these samples and their corresponding clinical information will be supported through Core A. RELEVANCE (See instructions): Core A is essential to ensure that all research activities in this SPORE utilizing human samples are provided with sound clinical and pathological information, that the data are efficiently and accurately managed, and that distribution of samples and data occurs in a reliable and timely manner.

该核心的目的是提供高质量的临床数据和主题样本以用于科学 孢子的项目。提供这些资源。核心A将利用和扩展临床和 每个机构已经存在的生物循环资源。对于其他或不同或不同的项目 需要样品/数据，这些样品的前瞻性收集及其相应的临床 信息将通过核心A支持。 相关性（请参阅说明）： 核心A对于确保提供了使用人类样品的所有孢子中的所有研究活动至关重要 通过合理的临床和病理信息，数据可以有效，准确地管理，并且 样本和数据的分布以可靠和及时的方式发生。